Rare Disease Day – Raising Awareness
Argonaut manufactures orphan drugs, including many personalized medicines for patients with rare conditions. Leading up to Rare Disease Day on February 28, we have been
Category: Drug Product Manufacturing
Sterile manufacturing got complicated. Isolator-based fill-finish is why.
Since the 1970’s, aseptic fill-finish has undergone multiple shifts from manual, sponsor-led operations in laminar airflow cleanrooms to highly specialized, isolator-based manufacturing. In the Trailblazers
Josh de Los Santos – Employee Spotlight
Meet Josh de Los Santos – Senior Manager, Drug Product Manufacturing at Argonaut From N-of-1 fills, to thousands of vials, Josh’s team delivers sterile fills
Raj Puri – Employee Spotlight
Meet Raj Puri – Chief Commercial Officer at Argonaut What’s a day in the life of a CCO at Argonaut? “Every day is truly different
Rick Hancock appointed as CEO to lead next phase of growth
Argonaut Manufacturing Services appoints Rick Hancock as Chief Executive Officer to lead next phase of growth Carlsbad, CA, November 2025 – Argonaut Manufacturing Services, a
Dain Hughen – Employee Spotlight
Meet Dain Hughen – Director of Validation at Argonaut What’s a day in the life of a Director of Validation at Argonaut? “There’s a plan
Jennifer Giddings – Employee Spotlight
Meet Jennifer Giddings – Sr. Program Manager at Argonaut What’s a day in the life of a Program Manager like at Argonaut? “As a Program
GMP Compliant Storage and Logistics for Biotech and Pharma
Why Argonaut Leads in GMP Compliant Storage and Logistics for Biotech and Pharma In today’s competitive biotech and pharmaceutical landscape, efficient supply chain management isn’t
Scott Goldstein – Employee Spotlight
Meet Scott Goldstein – Vice President of Strategic Partnerships, Drug Product Manufacturing at Argonaut Can you describe your role at Argonaut? No two days are
Broad Institute Selects Argonaut to Manufacture Compound for Potential Clinical Trial
Argonaut Manufacturing Services Selected to Manufacture siRNA Medicines for Potential Prion Disease Trial Argonaut to support manufacturing needs of an siRNA therapeutic for a potential